DOCSLIB.ORG

List of Diseases

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
List of Diseases List of Diseases Click the broad disease category name to see the list of specific diseases that belong to the category. 1. AI – Autoimmune disease 2. ALL – Acute lymphoblastic leukemia 3. AML – Acute myelogenous leukemia 4. CML - Chronic myeloid leukemia 5. CPV – Cardio and peripheral vascular disease 6. HIS – Histiocytic disease 7. HL – Hodgkin lymphoma 8. IEA – Inherited abnormalities of erythrocyte differentiation 9. IIS – Disorders of the immune system 10. IMD – Inherited disorders of metabolism 11. IPA – Inherited platelet abnormalities 12. MDS – Myelodysplastic diseases 13. MPS – Myeloproliferative diseases 14. MUS - Musculoskeletal disease 15. NEU – Neurological disease 16. NHL – Non Hodgkin lymphoma 17. OAL – Acute leukemia, other 18. OL – Leukemia, other 19. OTH - Other disease 20. PCD – Multiple myeloma/ plasma cell disease 21. SAA – Severe aplastic anemia 22. STU – Solid tumors Autoimmune disease (AI) AI – Crohn’s disease AI – Diabetes mellitus type I AI – Evan syndrome AI – Hemolytic anemia AI – Juvenile idiopathic arthritis: oligoarticular AI – Multiple sclerosis AI – not otherwise specified AI – Other autoimmune bowel disease AI – Other autoimmune cytopenia (low blood counts) AI – Other autoimmune neurologic disease AI – Other connective tissue disease AI – Other vasculitis AI – Rheumatoid arthritis AI – Systemic sclerosis (scleroderma) AI – Systemic lupus erythematosis (SLE) AI – Ulcerative colitis Back to the broad category list Acute lymphoblastic leukemia (ALL) • ALL – Hyperdiploidy (51-65 chromosomes) • ALL – Hypodiploidy (<45 chromosomes) • ALL – not otherwise specified • ALL – Precursor B-cell ALL • ALL – Precursor T-cell ALL • ALL – t(1;19) • ALL – t(12;21) • ALL – t(9;22) • ALL – t(v;11q23); MLL rearranged Back to the broad category list Acute myelogenous leukemia (AML or ANLL) AML – Acute basophilic leukemia AML – Acute erythroid leukemia (erythroid / myeloid and pure erythroleukemia) (M6) AML – Acute megakaryoblastic leukemia (M7) AML – Acute monoblastic / acute monocytic leukemia (M5) AML – Acute myelomonocytic leukemia (M4) AML – Acute panmyelosis with myelofibrosis AML – APL with t(15;17) and variant (M3) AML – Blastic plasmacytoid dendritic cell neoplasm AML – Megakaryoblastic with (1;22) AML – Minimally differentiated (M0) AML – Myeloid sarcoma AML – not otherwise specified AML – Therapy related AML (t-AML) AML – with 11q23 (MLL) abnormalities (i.e., t(4;11), t(6;11), t(9;11), t(11;19)) AML – with inv(16); or t(16;16) AML – with inv(3) or t(3;3) AML – with maturation (M2) AML – with multi-lineage dysplasia AML – with t(6;9) AML – with t(8;21) AML – with t(9;11) AML – without maturation (M1) Back to the broad category list Cardio and peripheral vascular disease (CPV) CPV – Heart attack CPV – not otherwise specified Back to the broad category list Histiocytic disorders (HIS) HIS – Hemophagocytic lymphohistiocytosis (HLH) HIS – Hemophagocytosis HIS – Langerhans cell histiocytosis (histiocytosis-X) HIS – Malignant histiocytosis HIS – not otherwise specified HIS – Other histiocytic disease Back to the broad category list Hodgkin lymphoma (HL) HL – Lymphocyte depleted HL – Lymphocyte-rich HL – Mixed cellularity HL – Nodular lymphocyte predominant Hodgkin lymphoma HL – Nodular sclerosis HL – not otherwise specified Back to the broad category list Inherited abnormalities of erythrocyte differentiation or function (IEA) IEA – Beta thalassemia major IEA – Diamond-Blackfan anemia IEA – Fanconi anemia IEA – not otherwise specified IEA – Other constitutional anemia IEA – Other hemoglobinopathy IEA – Paroxysmal nocturnal hemoglobinuria (PNH) IEA – Shwachmann-Diamond syndrome IEA – Sickle cell anemia IEA – Sickle thalassemia Back to the broad category list Disorders of the immune system (IIS) IIS – Bare lymphocyte syndrome IIS – Cartilage hair hypoplasia IIS – CD40 ligand deficiency IIS – Chediak-Higashi syndrome IIS – Chronic granulomatous disease IIS – Common variable immunodeficiency IIS – DiGeorge anomaly IIS – Immune deficiency, not otherwise specified IIS – Kostmann agranulocytosis (congenital neutropenia) IIS – Leukocyte adhesion deficiency IIS – Omenn syndrome IIS – Reticular dysgenesis IIS – Severe combined immunodeficiency (SCID) IIS – Wiskott-Aldrich syndrome (WAS) IIS – X-linked lymphoproliferative syndrome Back to the broad category list Inherited disorders of metabolism (IMD) IMD – Adrenoleukodystrophy (ALD) IMD – Beta-glucuronidase deficiency (VII) IMD – Gaucher disease IMD – Hunter syndrome IMD – Hurler syndrome (mps-ih or mps i) IMD – I cell disease IMD – Krabbe disease IMD – Lesch-Nyhan (HGPRT deficiency) IMD – Mannosidosis IMD – Maroteaux-Lamy IMD – Metachromatic leukodystrophy (MLD) IMD – Mucolipidosis, not otherwise specified IMD – Mucopolysaccharidosis, not otherwise specified IMD – Neimann - Pick disease IMD – Neuronal ceriod lipofuscinosis (Batten disease) IMD – not otherwise specified IMD – Osteopetrosis IMD – Sanfilippo (III) IMD – Wolman disease Back to the broad category list Inherited abnormalities of platelets (IPA) IPA – Congenital amegakaryocytosis/congenital thrombocytopenia IPA – Glanzmann thrombasthenia IPA – not otherwise specified IPA – Other inherited platelet abnormality Back to the broad category list Myelodysplastic / myeloproliferative diseases (MDS / MPS) Myelodysplastic diseases (MDS) MDS – 5q minus syndrome MDS – Childhood myelodysplastic syndrome (Refractory cytopenia of childhood) MDS – Not otherwise specified MDS – Refractory Anemia MDS – Refractory Anemia with excess blasts MDS – Refractory anemia with ringed sideroblasts MDS – Refractory Cytopenia with Multilineage Dysplasia MDS – Refractory Cytopenia with Multilineage Dysplasia and Ringed Sideroblasts Myeloproliferative diseases (MPS) MPS – Chronic eosinophilic leukemia (hypereosinophilic syndrome) MPS – Chronic neutrophilic leukemia MPS – Essential thrombocythemia MPS – Myeloproliferative neoplasm (MPN), unclassifiable MPS – Not otherwise specified MPS – Polycythemia vera MPS – Primary myelofibrosis Myelodysplastic / Myeloproliferative Diseases (MDS/MPN) MDS/MPS – Atypical chronic myeloid leukemia MDS/MPS – Chronic myelomonocytic leukemia MPS/MPS – Juvenile chronic myelomonocytic leukemia Back to the broad category list Neurological disease (NEU) NEU – Cerebral palsy NEU – Congenital hydrocephalus NEU – not otherwise specified Back to the broad category list Non-Hodgkin lymphoma (NHL) NHL – Adult T-cell lymphoma/leukemia NHL – Aggressive NK cell leukemia NHL – Anaplastic large cell lymphoma, T-cell primary cutaneous type NHL – Anaplastic large cell lymphoma, T-cell primary systemic type NHL – Anaplastic large-cell lymphoma, ALK negative NHL – Anaplastic large-cell lymphoma, ALK positive NHL – Angiommunoblastic T-cell lymphoma NHL – B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and Burkitt lymphoma NHL – B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and classical Hodgkin Lymphoma NHL – Burkitt lymphoma NHL – Enteropathy-type T-cell lymphoma NHL – Extranodal marginal zone B-cell lymphoma of mucosal associated lymphoid tissue type NHL – Extranodal NK/T-cell lymphoma, nasal type NHL – Follicular (grade unknown) NHL – Follicular, mixed, small cleaved and large cell (Grade II follicle center lymphoma) NHL – Follicular, predominantly large cell (Grade III follicle center lymphoma) NHL – Follicular, predominantly large cell (Grade IIIA follicle center lymphoma) NHL – Follicular, predominantly large cell (Grade IIIB follicle center lymphoma) NHL – Follicular, predominantly small cleaved cell (Grade I follicle center lymphoma) NHL – Hepatosplenic gamma-delta T-cell lymphoma NHL – High grade B-cell lymphoma, Burkitt-like NHL – Large t cell granular lymphocytic leukemia NHL – Lymphoplasmacytic lymphoma NHL – Mantle cell lymphoma NHL – Mycosis fungoides NHL – Nodal marginal zone B-cell lymphoma NHL – Diffuse large B cell lymphoma NHL – not otherwise specified NHL – Other B cell lymphoma NHL – Other T-cell/NK-cell lymphoma NHL – Peripheral T-cell lymphoma NHL – Primary CNS lymphoma NHL – Sezary syndrome NHL – Splenic marginal zone B-cell lymphoma NHL – Subcutaneous panniculitis-like T-cell lymphoma NHL – T-cell / histiocytic rich large B-cell lymphoma NHL – Waldenstrom macroglobulinemia Back to the broad category list Acute Leukemia, other (OAL) OAL – Acute mast cell leukemia OAL – Biphenotypic leukemia OAL – not otherwise specified Back to the broad category list Leukemia, Other (OL) OL – Chronic lymphocytic leukemia (CLL) OL – Hairy cell leukemia OL – not otherwise specified OL – Prolymphocytic leukemia (PLL) Back to the broad category list Multiple myeloma / Plasma cell disorder (PCD) PCD – Amyloidosis PCD – Light chain deposition disease PCD – Multiple myeloma PCD – not otherwise specified PCD – Osteosclerotic myeloma / POEMS syndrome PCD – Plasma cell leukemia PCD – Solitary plasmacytoma Back to the broad category list Severe aplastic anemia (SAA) SAA – Acquired pure red cell aplasia SAA – Amegakaryocytosis (not congenital) SAA – Dyskeratosis congenita SAA – not otherwise specified SAA – Severe aplastic anemia Back to the broad category list Solid tumors (STU) STU – Bone sarcoma (excluding Ewing family tumors) STU – Breast cancer STU – Central nervous system tumor STU – Ewing family tumors extra-osseous (includes PNET) STU – Ewing family tumors of bone (includes PNET) STU – Germ cell tumors STU – Head and neck cancer STU – Hepatobiliary (Liver or Gall Bladder Cancer) STU – Mediastinal neoplasm STU – Medulloblastoma STU – Neuroblastoma STU – not otherwise specified STU – Ovary STU – Renal cell carcinoma STU – Retinoblastoma STU – Rhabdomyosarcoma STU – Soft tissue sarcoma STU – Testicular STU – Thymoma STU – Wilm tumor Back to the broad category list .
Load more

Recommended publications
  • ICD-10-CM Expert for SNF, IRF, and LTCH the Complete Official Code Set Codes Valid from October 1, 2018 Through September 30, 2019
    EXPERT 2019 ICD-10-CM Expert for SNF, IRF, and LTCH The complete official code set Codes valid from October 1, 2018 through September 30, 2019 Power up your coding optum360coding.com ITSN_ITSN19_CVR.indd 1 12/4/17 2:54 PM Contents Preface ................................................................................ iii ICD-10-CM Index to Diseases and Injuries .......................... 1 ICD-10-CM Official Preface ........................................................................iii Characteristics of ICD-10-CM ....................................................................iii ICD-10-CM Neoplasm Table ............................................ 331 What’s New for 2019 .......................................................... iv ICD-10-CM Table of Drugs and Chemicals ...................... 349 Official Updates ............................................................................................iv Proprietary Updates ...................................................................................vii ICD-10-CM Index to External Causes ............................... 397 Introduction ....................................................................... ix ICD-10-CM Tabular List of Diseases and Injuries ............ 433 History of ICD-10-CM .................................................................................ix Chapter 1. Certain Infectious and Parasitic Diseases (A00-B99) .........................................................................433 How to Use ICD-10-CM Expert for Skilled Nursing Chapter
    [Show full text]
  • Café Au Lait Spots As a Marker of Neuropaediatric Diseases
    Mini Review Open Access J Neurol Neurosurg Volume 3 Issue 5 - May 2017 DOI: 10.19080/OAJNN.2017.03.555622 Copyright © All rights are reserved by Francisco Carratalá-Marco Café Au Lait Spots as a Marker of Neuropaediatric Diseases Francisco Carratalá-Marco1*, Rosa María Ruiz-Miralles2, Patricia Andreo-Lillo1, Julia Dolores Miralles-Botella3, Lorena Pastor-Ferrándiz1 and Mercedes Juste-Ruiz2 1Neuropaediatric Unit, University Hospital of San Juan de Alicante, Spain 2Paediatric Department, University Hospital of San Juan de Alicante, Spain 3Dermatology Department, University Hospital of San Juan de Alicante, Spain Submission: March 22, 2017; Published: May 10, 2017 *Corresponding author: Francisco Carratalá-Marco, Neuropaediatric Unit, University Hospital of San Juan de Alicante, Spain, Tel: ; Email: Abstract Introduction: want to know in which The measure,Café au lait the spots presence (CALS) of isolated are shown CALS in representsthe normal a population risk factor forwithout neurological pathological disease. significance, although they could also be criteria for some neurologic syndromes. Unspecific association with general neurologic illnesses has been less frequently described. We Patients and methods: We set up an observational transversal study of cases, patients admitted for neuropaediatric reasons (NPP; n=49) excluding all the patients suffering from neurologic illnesses associated to CALS, and controls, a hospital simultaneously admitted pediatric population for non-neurologic causes (CP; n=101) since October 2012 to January 2013. The data were collected from the clinical reports at admission, and then analyzed by SPSS 22.0 statistical package, and the Stat Calc module of EpiInfo 7.0, following the ethics current rules of the institution for observational studies.
    [Show full text]
  • A Brief Evaluation and Image Formation of Pediatrics Nutritional Forum in Opinion Sector Disouja Wills* Nutritonal Sciences, Christian Universita Degli Studo, Italy
    d Pediatr Wills, Matern Pediatr Nutr 2016, 2:2 an ic l N a u n t DOI: 10.4172/2472-1182.1000113 r r e i t t i o Maternal and Pediatric a n M ISSN: 2472-1182 Nutrition ShortResearch Commentary Article OpenOpen Access Access A Brief Evaluation and Image formation of Pediatrics Nutritional Forum in Opinion Sector Disouja Wills* Nutritonal Sciences, Christian Universita degli studo, Italy Abstract Severe most and one of the main global threat is Nutritional disorders to backward countries, with respect to this issue WHO involved and trying to overcome this issue with the Co-ordination of INF and BNF. International Nutrition Foundation and British Nutrition Foundation, development in weight gain through proper nutrition and proper immune mechanism in the kids is their main role to eradicate and overcome nutritional problems in world. Keywords: INF; BNF; Malnutrition; Merasmus; Rickets; Weight loss; Precautions to Avoid Nutrition Deficiency in Paediatric health issue Paediatrics Introduction Respective disease having respective deficiency dis order but in the case of nutritional diseases. Proper nutrition is the only thing to cure In the mankind a respective one health and weight gain is fully nutritional disorders. Providing sufficient diet like fish, meat, egg, milk based on perfect nutritional intake which he is having daily, poor diet to malnourished kids and consuming beef, fish liver oil, sheep meat, will show the improper impact and injury to the some of the systems boiled eggs from the age of 3 itself (Tables 1 and 2). in the body, total health also in some times. Blindness, Scurvy, Rickets will be caused by nutritional deficiency disorders only, mainly in kids.
    [Show full text]
  • Neonatal Orthopaedics
    NEONATAL ORTHOPAEDICS NEONATAL ORTHOPAEDICS Second Edition N De Mazumder MBBS MS Ex-Professor and Head Department of Orthopaedics Ramakrishna Mission Seva Pratishthan Vivekananda Institute of Medical Sciences Kolkata, West Bengal, India Visiting Surgeon Department of Orthopaedics Chittaranjan Sishu Sadan Kolkata, West Bengal, India Ex-President West Bengal Orthopaedic Association (A Chapter of Indian Orthopaedic Association) Kolkata, West Bengal, India Consultant Orthopaedic Surgeon Park Children’s Centre Kolkata, West Bengal, India Foreword AK Das ® JAYPEE BROTHERS MEDICAL PUBLISHERS (P) LTD. New Delhi • London • Philadelphia • Panama (021)66485438 66485457 www.ketabpezeshki.com ® Jaypee Brothers Medical Publishers (P) Ltd. Headquarters Jaypee Brothers Medical Publishers (P) Ltd. 4838/24, Ansari Road, Daryaganj New Delhi 110 002, India Phone: +91-11-43574357 Fax: +91-11-43574314 Email: [email protected] Overseas Offices J.P. Medical Ltd. Jaypee-Highlights Medical Publishers Inc. Jaypee Brothers Medical Publishers Ltd. 83, Victoria Street, London City of Knowledge, Bld. 237, Clayton The Bourse SW1H 0HW (UK) Panama City, Panama 111, South Independence Mall East Phone: +44-2031708910 Phone: +507-301-0496 Suite 835, Philadelphia, PA 19106, USA Fax: +02-03-0086180 Fax: +507-301-0499 Phone: +267-519-9789 Email: [email protected] Email: [email protected] Email: [email protected] Jaypee Brothers Medical Publishers (P) Ltd. Jaypee Brothers Medical Publishers (P) Ltd. 17/1-B, Babar Road, Block-B, Shaymali Shorakhute, Kathmandu Mohammadpur, Dhaka-1207 Nepal Bangladesh Phone: +00977-9841528578 Mobile: +08801912003485 Email: [email protected] Email: [email protected] Website: www.jaypeebrothers.com Website: www.jaypeedigital.com © 2013, Jaypee Brothers Medical Publishers All rights reserved. No part of this book may be reproduced in any form or by any means without the prior permission of the publisher.
    [Show full text]
  • EFFECTIVE NEBRASKA DEPARTMENT of 01/01/2017 HEALTH and HUMAN SERVICES 173 NAC 1 I TITLE 173 COMMUNICABLE DISEASES CHAPTER 1
    EFFECTIVE NEBRASKA DEPARTMENT OF 01/01/2017 HEALTH AND HUMAN SERVICES 173 NAC 1 TITLE 173 COMMUNICABLE DISEASES CHAPTER 1 REPORTING AND CONTROL OF COMMUNICABLE DISEASES TABLE OF CONTENTS SECTION SUBJECT PAGE 1-001 SCOPE AND AUTHORITY 1 1-002 DEFINITIONS 1 1-003 WHO MUST REPORT 2 1-003.01 Healthcare Providers (Physicians and Hospitals) 2 1-003.01A Reporting by PA’s and APRN’s 2 1-003.01B Reporting by Laboratories in lieu of Physicians 3 1-003.01C Reporting by Healthcare Facilities in lieu of Physicians for 3 Healthcare Associated Infections (HAIs) 1-003.02 Laboratories 3 1-003.02A Electronic Ordering of Laboratory Tests 3 1-004 REPORTABLE DISEASES, POISONINGS, AND ORGANISMS: 3 LISTS AND FREQUENCY OF REPORTS 1-004.01 Immediate Reports 4 1-004.01A List of Diseases, Poisonings, and Organisms 4 1-004.01B Clusters, Outbreaks, or Unusual Events, Including Possible 5 Bioterroristic Attacks 1-004.02 Reports Within Seven Days – List of Reportable Diseases, 5 Poisonings, and Organisms 1-004.03 Reporting of Antimicrobial Susceptibility 8 1-004.04 New or Emerging Diseases and Other Syndromes and Exposures – 8 Reporting and Submissions 1-004.04A Criteria 8 1-004.04B Surveillance Mechanism 8 1-004.05 Sexually Transmitted Diseases 9 1-004.06 Healthcare Associated Infections 9 1-005 METHODS OF REPORTING 9 1-005.01 Health Care Providers 9 1-005.01A Immediate Reports of Diseases, Poisonings, and Organisms 9 1-005.01B Immediate Reports of Clusters, Outbreaks, or Unusual Events, 9 Including Possible Bioterroristic Attacks i EFFECTIVE NEBRASKA DEPARTMENT OF
    [Show full text]
  • Federal Register/Vol. 69, No. 194/Thursday, October 7, 2004
    Federal Register / Vol. 69, No. 194 / Thursday, October 7, 2004 / Rules and Regulations 60083 Regulations Branch, Office of drawback requested on the drawback war are decided fairly, consistently, and Regulations and Rulings, U.S. Customs entry. This is determined as follows: based on all available medical and Border Protection. However, * * * * * information concerning the diseases personnel from other offices I 4. In § 191.171, a new paragraph (c) is associated with detention or internment participated in its development. added to read as follows: as a prisoner of war. DATES: List of Subjects in 19 CFR Part 191 This interim final rule is § 191.171 General; drawback allowance. effective October 7, 2004. Comments Claims, Commerce, CBP duties and * * * * * must be received on or before November inspection, Drawback. (c) Merchandise processing fees. In 8, 2004. cases where the requirements of Amendments to the Regulations ADDRESSES: Written comments may be paragraph (b)(1) of this section have submitted by: mail or hand-delivery to I For the reasons stated above, part 191 been met, merchandise processing fees Director, Regulations Management of the CBP Regulations (19 CFR part 191) will be eligible for drawback. (00REG1), Department of Veterans is amended as follows: Approved: October 4, 2004. Affairs, 810 Vermont Ave., NW., Room Robert C. Bonner, 1068, Washington, DC 20420; fax to PART 191 — DRAWBACK Commissioner, U.S. Customs and Border (202) 273–9026; e-mail to I 1. The general authority citation for Protection. [email protected]; or, through part 191 continues to read as follows: Timothy E. Skud, http://www.Regulations.gov. Comments Deputy Assistant Secretary of the Treasury.
    [Show full text]
  • Disease Discovery Classification of Lymphoid Neoplasms
    From www.bloodjournal.org by on December 4, 2008. For personal use only. 2008 112: 4384-4399 doi:10.1182/blood-2008-07-077982 Classification of lymphoid neoplasms: the microscope as a tool for disease discovery Elaine S. Jaffe, Nancy Lee Harris, Harald Stein and Peter G. Isaacson Updated information and services can be found at: http://bloodjournal.hematologylibrary.org/cgi/content/full/112/12/4384 Articles on similar topics may be found in the following Blood collections: Neoplasia (4200 articles) Free Research Articles (544 articles) ASH 50th Anniversary Reviews (32 articles) Clinical Trials and Observations (2473 articles) Information about reproducing this article in parts or in its entirety may be found online at: http://bloodjournal.hematologylibrary.org/misc/rights.dtl#repub_requests Information about ordering reprints may be found online at: http://bloodjournal.hematologylibrary.org/misc/rights.dtl#reprints Information about subscriptions and ASH membership may be found online at: http://bloodjournal.hematologylibrary.org/subscriptions/index.dtl Blood (print ISSN 0006-4971, online ISSN 1528-0020), is published semimonthly by the American Society of Hematology, 1900 M St, NW, Suite 200, Washington DC 20036. Copyright 2007 by The American Society of Hematology; all rights reserved. From www.bloodjournal.org by on December 4, 2008. For personal use only. ASH 50th anniversary review Classification of lymphoid neoplasms: the microscope as a tool for disease discovery Elaine S. Jaffe,1 Nancy Lee Harris,2 Harald Stein,3 and Peter
    [Show full text]
  • Study Guide Medical Terminology by Thea Liza Batan About the Author
    Study Guide Medical Terminology By Thea Liza Batan About the Author Thea Liza Batan earned a Master of Science in Nursing Administration in 2007 from Xavier University in Cincinnati, Ohio. She has worked as a staff nurse, nurse instructor, and level department head. She currently works as a simulation coordinator and a free- lance writer specializing in nursing and healthcare. All terms mentioned in this text that are known to be trademarks or service marks have been appropriately capitalized. Use of a term in this text shouldn’t be regarded as affecting the validity of any trademark or service mark. Copyright © 2017 by Penn Foster, Inc. All rights reserved. No part of the material protected by this copyright may be reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, or by any information storage and retrieval system, without permission in writing from the copyright owner. Requests for permission to make copies of any part of the work should be mailed to Copyright Permissions, Penn Foster, 925 Oak Street, Scranton, Pennsylvania 18515. Printed in the United States of America CONTENTS INSTRUCTIONS 1 READING ASSIGNMENTS 3 LESSON 1: THE FUNDAMENTALS OF MEDICAL TERMINOLOGY 5 LESSON 2: DIAGNOSIS, INTERVENTION, AND HUMAN BODY TERMS 28 LESSON 3: MUSCULOSKELETAL, CIRCULATORY, AND RESPIRATORY SYSTEM TERMS 44 LESSON 4: DIGESTIVE, URINARY, AND REPRODUCTIVE SYSTEM TERMS 69 LESSON 5: INTEGUMENTARY, NERVOUS, AND ENDOCRINE S YSTEM TERMS 96 SELF-CHECK ANSWERS 134 © PENN FOSTER, INC. 2017 MEDICAL TERMINOLOGY PAGE III Contents INSTRUCTIONS INTRODUCTION Welcome to your course on medical terminology. You’re taking this course because you’re most likely interested in pursuing a health and science career, which entails ­proficiency­in­communicating­with­healthcare­professionals­such­as­physicians,­nurses,­ or dentists.
    [Show full text]
  • Connecticut Insurance Coverage for Specialized Formula; New York's “Hannah's Law”
    OLR RESEARCH REPORT July 5, 2012 2012-R-0304 CONNECTICUT INSURANCE COVERAGE FOR SPECIALIZED FORMULA; NEW YORK'S “HANNAH'S LAW” By: Janet L. Kaminski Leduc, Senior Legislative Attorney You asked if Connecticut law requires health insurance policies to cover specialized formula used for treating eosinophilic disorder. You also asked for a description of New York’s “Hannah’s Law.” SUMMARY Connecticut insurance law does not explicitly require health insurance policies to cover specialized formulas for treating eosinophilic disorder. However, the law requires specified health insurance policies to cover medically necessary specialized formula for children up to age 12 for treating a disease or condition when the formula is administered under a physician’s direction. Thus, it appears that this would include coverage of specialized formulas for treating eosinophilic disorder. Anyone denied such coverage may appeal to their insurance carrier (internal appeal) or the Insurance Department (external appeal). The explanation of benefits from the carrier describes the appeal process. Anyone with concerns or questions about his or her insurance coverage may contact the Insurance Department’s Consumer Affairs Division at (800) 203-3447 or (860) 297-3900. More information about contacting the department is available at http://www.ct.gov/cid/cwp/view.asp?q=254352. Sandra Norman-Eady, Director Room 5300 Phone (860) 240-8400 Legislative Office Building FAX (860) 240-8881 Connecticut General Assembly Hartford, CT 06106-1591 http://www.cga.ct.gov/olr Office of Legislative Research [email protected] A bill (“Hannah’s Law”) in the New York Assembly would require health insurance policies to cover the cost of enteral formulas for treating eosinophilic esophagitis and related eosinophilic disorders.
    [Show full text]
  • Eye Disease 1 Eye Disease
    Eye disease 1 Eye disease Eye disease Classification and external resources [1] MeSH D005128 This is a partial list of human eye diseases and disorders. The World Health Organisation publishes a classification of known diseases and injuries called the International Statistical Classification of Diseases and Related Health Problems or ICD-10. This list uses that classification. H00-H59 Diseases of the eye and adnexa H00-H06 Disorders of eyelid, lacrimal system and orbit • (H00.0) Hordeolum ("stye" or "sty") — a bacterial infection of sebaceous glands of eyelashes • (H00.1) Chalazion — a cyst in the eyelid (usually upper eyelid) • (H01.0) Blepharitis — inflammation of eyelids and eyelashes; characterized by white flaky skin near the eyelashes • (H02.0) Entropion and trichiasis • (H02.1) Ectropion • (H02.2) Lagophthalmos • (H02.3) Blepharochalasis • (H02.4) Ptosis • (H02.6) Xanthelasma of eyelid • (H03.0*) Parasitic infestation of eyelid in diseases classified elsewhere • Dermatitis of eyelid due to Demodex species ( B88.0+ ) • Parasitic infestation of eyelid in: • leishmaniasis ( B55.-+ ) • loiasis ( B74.3+ ) • onchocerciasis ( B73+ ) • phthiriasis ( B85.3+ ) • (H03.1*) Involvement of eyelid in other infectious diseases classified elsewhere • Involvement of eyelid in: • herpesviral (herpes simplex) infection ( B00.5+ ) • leprosy ( A30.-+ ) • molluscum contagiosum ( B08.1+ ) • tuberculosis ( A18.4+ ) • yaws ( A66.-+ ) • zoster ( B02.3+ ) • (H03.8*) Involvement of eyelid in other diseases classified elsewhere • Involvement of eyelid in impetigo
    [Show full text]
  • DIAGNOSIS and TREATMENT of BRUCELLOSIS (Undulant Fever)
    DIAGNOSIS AND TREATMENT OF BRUCELLOSIS (Undulant Fever) CHARLES L. HARTSOCK, M.D. Not only the treatment but also the diagnosis of undulant fever are far from being satisfactory, although many types of therapy are being tried and critically evaluated. Because of the tremendous scope of the disease, frequent discussions and reappraisals of our ideas about bru- cellosis will be absolutely essential for some time. Some physicians more or less disregard brucellosis and even scoff at the chronic phase of this new intruder in the realm of human disease. Others are overenthusi- astic and attempt to explain many vague and indefinite problems upon the basis of chronic brucellosis without sufficient evidence. Still other physicians have lost their original enthusiasm and have reverted to the first viewpoint, probably because of the great difficulty in coping with the caprices and vagaries of this disease and the marked uncertainties in diagnosis and treatment. Even though this disease is extremely protean and remarkably bizarre in its manifestations, it is a disease of known causative organism to which the generic term of brucella has been given. The original infection in man was traced to the drinking of goat's milk on the Island of Malta, and for many years this disease was known as Malta fever. Because of the undulating character of the fever with a tendency for remissions and recurrences, it was later called undulant fever which proved to be a very poor description of the febrile reaction in many instances. Brucellosis is the more specific term derived from the organism causing the disease. Three strains of the brucella organism have been isolated and named for their respective hosts: b.
    [Show full text]
  • 20) Thyrotoxicosis
    1 Міністерство охорони здоров’я України Харківський національний медичний університет Кафедра Внутрішньої медицини №3 Факультет VI по підготовці іноземних студентів ЗАТВЕРДЖЕНО на засіданні кафедри внутрішньої медицини №3 «29» серпня 2016 р. протокол № 13 Зав. кафедри _______д.мед.н., професор Л.В. Журавльова МЕТОДИЧНІ ВКАЗІВКИ для студентів з дисципліни «Внутрішня медицина (в тому числі з ендокринологією) студенти 4 курсу І, ІІ, ІІІ медичних факультетів, V та VI факультетів по підготовці іноземних студентів Тиреотоксикоз. Клінічні форми, діагностика, лікування. Пухлини щитоподібної залоз та патологія при щитоподібних залоз Харків 2016 2 Topic – «Thyrotoxicosis. Clinical forms, diagnostic, treatment. Tumors of thyreoid gland and pathology of parathyroid glands» 1.The number of hours - 5 Actuality: Thyroid gland disease is one of the most popular in Ukraine affect patients of working age, degrade the quality of life and reduce its duration. Aim: 1. To learn the method of determining the etiologic factors and pathogenesis of diffuse toxic goiter. Work out techniques of palpation of the thyroid gland. 2. To familiarize students with the classifications of goiter by OV.Nikolaєv (1955 г.) And WHO (1992 г.). 3. To distinguish a typical clinical picture of diffuse toxic goiter (DTG). 4. To acquainte with the atypical clinical variants of diffuse toxic goiter. 5. To acquaint students with the possible complications of DTG. 6. To determine the basic diagnostic criteria for Graves' disease 7. To make a plan to examinate patients with Graves' disease. 8. Analysis of the results of laboratory and instrumental studies, which are used for the diagnosis of DTG. 9. Differential diagnosis between DTG and goiter 10. Technology of formulation of the diagnosis of DTG and goiter.
    [Show full text]